| 1.9 |
13.0 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.1 |
3.3 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 1.0 |
3.9 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 1.0 |
5.9 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.0 |
3.8 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.8 |
3.4 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.8 |
2.4 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.8 |
3.9 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.7 |
2.2 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 0.7 |
2.9 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 0.7 |
2.6 |
GO:0060266 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 0.6 |
3.2 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.6 |
1.9 |
GO:0046032 |
ADP catabolic process(GO:0046032) |
| 0.6 |
1.9 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.6 |
1.9 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.6 |
1.8 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.6 |
0.6 |
GO:0009202 |
deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
| 0.6 |
1.7 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 0.6 |
3.4 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.6 |
1.7 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.6 |
2.8 |
GO:0019249 |
lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
| 0.5 |
2.1 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.5 |
1.6 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
| 0.5 |
1.6 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.5 |
2.5 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.5 |
2.0 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.5 |
1.8 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.5 |
0.9 |
GO:0003104 |
positive regulation of glomerular filtration(GO:0003104) |
| 0.5 |
1.4 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.4 |
5.2 |
GO:0009209 |
pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
| 0.4 |
3.0 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.4 |
0.9 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.4 |
1.3 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 0.4 |
1.3 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.4 |
2.1 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) |
| 0.4 |
1.3 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.4 |
1.2 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.4 |
11.0 |
GO:0006220 |
pyrimidine nucleotide metabolic process(GO:0006220) |
| 0.4 |
2.0 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.4 |
1.2 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.4 |
1.6 |
GO:0061626 |
pharyngeal arch artery morphogenesis(GO:0061626) |
| 0.4 |
1.2 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.4 |
4.3 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.4 |
2.0 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.4 |
1.9 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.4 |
1.1 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.4 |
1.5 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.4 |
1.5 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.4 |
1.8 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.4 |
1.5 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.3 |
1.0 |
GO:0060785 |
regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
| 0.3 |
3.8 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.3 |
1.0 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.3 |
1.0 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.3 |
1.0 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.3 |
1.3 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.3 |
1.0 |
GO:0032714 |
negative regulation of interleukin-13 production(GO:0032696) negative regulation of interleukin-5 production(GO:0032714) |
| 0.3 |
1.3 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.3 |
1.3 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.3 |
0.7 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.3 |
1.3 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.3 |
1.0 |
GO:0046959 |
habituation(GO:0046959) |
| 0.3 |
4.1 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.3 |
0.9 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.3 |
1.6 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.3 |
1.2 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.3 |
2.1 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.3 |
0.9 |
GO:0010872 |
regulation of cholesterol esterification(GO:0010872) |
| 0.3 |
0.9 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.3 |
0.3 |
GO:1904008 |
response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 0.3 |
0.6 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.3 |
1.1 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.3 |
1.1 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.3 |
1.1 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.3 |
1.4 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.3 |
0.3 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.3 |
0.3 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.3 |
0.8 |
GO:0046084 |
adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
| 0.3 |
1.4 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.3 |
0.3 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
| 0.3 |
0.3 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.3 |
1.3 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.3 |
0.8 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.3 |
0.8 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.3 |
0.5 |
GO:0072179 |
nephric duct formation(GO:0072179) |
| 0.3 |
0.8 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.3 |
1.5 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.3 |
5.1 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.3 |
0.8 |
GO:0002118 |
aggressive behavior(GO:0002118) |
| 0.3 |
3.5 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.3 |
0.8 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.3 |
0.8 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.3 |
0.5 |
GO:0009189 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) 2'-deoxyribonucleotide biosynthetic process(GO:0009265) deoxyribose phosphate biosynthetic process(GO:0046385) |
| 0.3 |
0.5 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.2 |
0.7 |
GO:0006407 |
rRNA export from nucleus(GO:0006407) |
| 0.2 |
0.7 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.2 |
0.7 |
GO:0019043 |
establishment of viral latency(GO:0019043) |
| 0.2 |
0.5 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.2 |
0.7 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.2 |
0.7 |
GO:0010871 |
negative regulation of receptor biosynthetic process(GO:0010871) |
| 0.2 |
0.2 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.2 |
0.7 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.2 |
0.9 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.2 |
1.2 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.2 |
1.6 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.2 |
1.6 |
GO:0003229 |
ventricular cardiac muscle tissue development(GO:0003229) |
| 0.2 |
0.9 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.2 |
0.7 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 |
1.8 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.2 |
1.5 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.2 |
0.4 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.2 |
1.1 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.2 |
1.1 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.2 |
0.9 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 |
0.4 |
GO:0042921 |
glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.2 |
1.0 |
GO:0046037 |
GMP biosynthetic process(GO:0006177) GMP metabolic process(GO:0046037) |
| 0.2 |
1.9 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.2 |
3.3 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.2 |
4.1 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.2 |
2.4 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.2 |
0.4 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.2 |
0.8 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.2 |
1.4 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.2 |
0.2 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.2 |
0.6 |
GO:0010752 |
negative regulation of antigen processing and presentation(GO:0002578) negative regulation of nitric oxide mediated signal transduction(GO:0010751) regulation of cGMP-mediated signaling(GO:0010752) negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.2 |
0.8 |
GO:0050812 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.2 |
0.4 |
GO:2000157 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.2 |
0.6 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.2 |
0.4 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.2 |
0.6 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.2 |
0.4 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.2 |
0.4 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.2 |
0.9 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.2 |
0.6 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.2 |
1.1 |
GO:0051503 |
adenine nucleotide transport(GO:0051503) |
| 0.2 |
0.6 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.2 |
0.6 |
GO:0061209 |
cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 0.2 |
5.1 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.2 |
0.5 |
GO:1904139 |
microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
| 0.2 |
2.1 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 |
0.5 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.2 |
1.2 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.2 |
1.9 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.2 |
0.5 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.2 |
1.0 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 |
1.0 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 |
0.8 |
GO:0002922 |
positive regulation of humoral immune response(GO:0002922) |
| 0.2 |
0.5 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.2 |
0.3 |
GO:0021586 |
pons maturation(GO:0021586) |
| 0.2 |
1.5 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.2 |
0.5 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.2 |
0.3 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.2 |
2.5 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.2 |
1.0 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.2 |
0.5 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.2 |
0.5 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.2 |
0.5 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.2 |
0.3 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.2 |
0.9 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.2 |
0.2 |
GO:0018216 |
peptidyl-arginine methylation(GO:0018216) histone arginine methylation(GO:0034969) |
| 0.2 |
0.8 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.2 |
0.5 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.2 |
0.5 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.2 |
1.7 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.2 |
0.9 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.2 |
0.2 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.2 |
0.9 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.2 |
0.6 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 |
0.6 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.2 |
1.1 |
GO:1900194 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.2 |
1.4 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.1 |
1.2 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.1 |
0.9 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.1 |
0.4 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.1 |
1.2 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.1 |
1.3 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.1 |
0.6 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.1 |
0.4 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.1 |
0.4 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.1 |
0.4 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.1 |
0.4 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 |
0.4 |
GO:0046618 |
drug export(GO:0046618) |
| 0.1 |
1.1 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 |
0.3 |
GO:0072071 |
mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.1 |
1.1 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.1 |
0.4 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.1 |
1.3 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
2.2 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.1 |
1.2 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.1 |
0.3 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.1 |
0.5 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.1 |
1.1 |
GO:0003056 |
regulation of vascular smooth muscle contraction(GO:0003056) |
| 0.1 |
0.4 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.1 |
0.5 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.1 |
0.3 |
GO:0032055 |
negative regulation of translation in response to stress(GO:0032055) |
| 0.1 |
0.5 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.1 |
0.5 |
GO:0046487 |
glyoxylate metabolic process(GO:0046487) |
| 0.1 |
0.9 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
0.6 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.1 |
1.5 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.1 |
0.4 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.1 |
0.4 |
GO:0016056 |
rhodopsin mediated signaling pathway(GO:0016056) |
| 0.1 |
0.5 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.1 |
0.5 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.1 |
1.3 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
0.1 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.1 |
0.4 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.1 |
0.4 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.1 |
0.4 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.1 |
0.4 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 0.1 |
0.1 |
GO:0072600 |
establishment of protein localization to Golgi(GO:0072600) |
| 0.1 |
0.4 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.1 |
0.7 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
1.5 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.2 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.1 |
0.2 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.1 |
4.4 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.1 |
0.7 |
GO:0015817 |
histidine transport(GO:0015817) |
| 0.1 |
0.2 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.1 |
0.9 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.6 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.1 |
0.1 |
GO:0006706 |
steroid catabolic process(GO:0006706) |
| 0.1 |
0.3 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.1 |
2.1 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.1 |
0.2 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.1 |
0.8 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.1 |
2.6 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 |
0.6 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.5 |
GO:0070942 |
neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) |
| 0.1 |
0.2 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.1 |
0.9 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
2.0 |
GO:0046033 |
AMP metabolic process(GO:0046033) |
| 0.1 |
0.2 |
GO:0001839 |
neural plate morphogenesis(GO:0001839) |
| 0.1 |
2.8 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.1 |
0.3 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 |
0.7 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.1 |
0.6 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.1 |
3.2 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.1 |
0.1 |
GO:2000630 |
positive regulation of miRNA metabolic process(GO:2000630) |
| 0.1 |
0.3 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.1 |
0.7 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 |
0.8 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.4 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.1 |
0.4 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.1 |
0.2 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 0.1 |
1.2 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 |
0.3 |
GO:0097278 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) complement-dependent cytotoxicity(GO:0097278) |
| 0.1 |
0.3 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.1 |
0.5 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 |
0.9 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.1 |
0.3 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.1 |
0.1 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) vein smooth muscle contraction(GO:0014826) |
| 0.1 |
0.2 |
GO:1901984 |
negative regulation of protein acetylation(GO:1901984) |
| 0.1 |
0.6 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.1 |
1.3 |
GO:1902993 |
positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.1 |
0.2 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.1 |
0.3 |
GO:0010899 |
regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.1 |
0.4 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.1 |
0.3 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.1 |
2.1 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.1 |
0.9 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.1 |
0.8 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
1.4 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.1 |
0.3 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.1 |
0.8 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.1 |
1.2 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.1 |
0.3 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
0.4 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 |
0.4 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
0.3 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.1 |
0.3 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.1 |
1.1 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
0.4 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 0.1 |
0.5 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.1 |
0.4 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.1 |
1.0 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.8 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) |
| 0.1 |
0.2 |
GO:0060596 |
regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) mammary placode formation(GO:0060596) |
| 0.1 |
0.2 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
0.4 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.1 |
0.4 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) |
| 0.1 |
0.4 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.1 |
0.6 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.2 |
GO:0032079 |
regulation of endodeoxyribonuclease activity(GO:0032071) positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.1 |
0.2 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.1 |
0.3 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 |
0.3 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 |
0.5 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.1 |
0.5 |
GO:0032308 |
positive regulation of prostaglandin secretion(GO:0032308) |
| 0.1 |
2.5 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
0.8 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.1 |
1.9 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 |
0.4 |
GO:0090292 |
nuclear migration along microfilament(GO:0031022) nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 |
0.7 |
GO:0008637 |
apoptotic mitochondrial changes(GO:0008637) |
| 0.1 |
1.1 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
0.5 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.1 |
0.3 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.1 |
0.3 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.1 |
0.5 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 |
0.5 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.1 |
0.3 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
0.3 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.1 |
0.3 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.1 |
0.3 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.1 |
0.5 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.1 |
0.3 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 |
0.5 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.1 |
0.3 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 |
0.3 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.1 |
0.1 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.1 |
0.2 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.1 |
0.3 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.1 |
0.7 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.1 |
0.8 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.7 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 |
0.7 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.1 |
0.7 |
GO:0045842 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.1 |
0.3 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.1 |
0.7 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.1 |
1.2 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.1 |
0.2 |
GO:0060083 |
smooth muscle contraction involved in micturition(GO:0060083) |
| 0.1 |
0.4 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 |
0.3 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.1 |
0.2 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.1 |
0.4 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 |
1.0 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.1 |
0.5 |
GO:0090240 |
positive regulation of histone H4 acetylation(GO:0090240) |
| 0.1 |
0.5 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
0.7 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.1 |
0.3 |
GO:0002829 |
negative regulation of type 2 immune response(GO:0002829) regulation of T-helper 1 cell differentiation(GO:0045625) positive regulation of T-helper 1 cell differentiation(GO:0045627) negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.1 |
0.9 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.1 |
1.6 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 |
2.8 |
GO:0018279 |
protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 |
1.6 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.1 |
1.4 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 |
0.2 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
0.8 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.1 |
0.5 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
1.7 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.1 |
0.3 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.1 |
0.1 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.1 |
0.2 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.1 |
1.4 |
GO:0006024 |
glycosaminoglycan biosynthetic process(GO:0006024) |
| 0.1 |
0.3 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.1 |
1.0 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.1 |
0.4 |
GO:0046016 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.1 |
0.5 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.1 |
0.2 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.1 |
0.4 |
GO:0030166 |
proteoglycan biosynthetic process(GO:0030166) |
| 0.1 |
0.2 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 |
0.6 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.1 |
0.6 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.1 |
2.5 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 |
4.8 |
GO:0007405 |
neuroblast proliferation(GO:0007405) |
| 0.1 |
1.3 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
| 0.1 |
0.6 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
0.6 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
0.2 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.1 |
0.3 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
1.0 |
GO:0051084 |
'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
| 0.1 |
0.3 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.1 |
0.3 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 |
1.1 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.1 |
0.4 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 |
0.4 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
1.5 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.1 |
1.1 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.1 |
2.6 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 |
0.1 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 |
0.3 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) D-amino acid metabolic process(GO:0046416) |
| 0.1 |
0.2 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
0.1 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 |
0.4 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.1 |
0.7 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.1 |
0.1 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.1 |
0.3 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 |
0.2 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
0.2 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
0.2 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.1 |
0.3 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.1 |
0.7 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.8 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.2 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.1 |
0.6 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.1 |
0.2 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.1 |
0.4 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.1 |
1.2 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.1 |
0.5 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.1 |
0.8 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.4 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.1 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.1 |
0.5 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 |
0.2 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.1 |
3.6 |
GO:0006405 |
RNA export from nucleus(GO:0006405) |
| 0.1 |
0.3 |
GO:0051958 |
methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.1 |
0.6 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.1 |
0.2 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.1 |
0.4 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
0.6 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.1 |
0.2 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.1 |
0.3 |
GO:0046502 |
uroporphyrinogen III metabolic process(GO:0046502) |
| 0.1 |
0.3 |
GO:0046543 |
development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
| 0.1 |
0.5 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.1 |
0.5 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
0.2 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.1 |
2.2 |
GO:0009261 |
ribonucleotide catabolic process(GO:0009261) |
| 0.1 |
0.7 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.1 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.1 |
0.1 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 |
0.2 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.0 |
0.3 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.0 |
0.1 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.0 |
1.4 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 |
0.2 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.2 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 |
1.0 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.1 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.0 |
0.1 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.0 |
0.0 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 0.0 |
0.4 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.4 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.0 |
0.3 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.0 |
0.3 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 |
0.2 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) |
| 0.0 |
0.1 |
GO:0042524 |
negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
| 0.0 |
0.1 |
GO:0000237 |
leptotene(GO:0000237) |
| 0.0 |
0.3 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 |
0.5 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.0 |
0.3 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.0 |
0.2 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 |
1.9 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.9 |
GO:0051154 |
negative regulation of striated muscle cell differentiation(GO:0051154) |
| 0.0 |
0.3 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.0 |
0.3 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.0 |
0.3 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.4 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.0 |
0.1 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.0 |
0.1 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.0 |
0.6 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.0 |
2.7 |
GO:0061178 |
regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
| 0.0 |
0.4 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.0 |
1.0 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 0.0 |
1.4 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 |
0.4 |
GO:0010884 |
positive regulation of lipid storage(GO:0010884) |
| 0.0 |
0.8 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 |
0.5 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.3 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.0 |
0.8 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.0 |
0.2 |
GO:0070831 |
basement membrane assembly(GO:0070831) |
| 0.0 |
0.2 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.0 |
1.6 |
GO:0007584 |
response to nutrient(GO:0007584) |
| 0.0 |
0.3 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.0 |
0.3 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.0 |
0.1 |
GO:0061117 |
negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
| 0.0 |
0.7 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.6 |
GO:0099500 |
synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.0 |
0.4 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.0 |
1.0 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.5 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.0 |
0.7 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.0 |
0.5 |
GO:0060914 |
heart formation(GO:0060914) |
| 0.0 |
0.1 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.0 |
0.1 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
0.7 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.2 |
GO:1903056 |
melanocyte migration(GO:0097324) regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.0 |
0.2 |
GO:0009992 |
cellular water homeostasis(GO:0009992) |
| 0.0 |
0.3 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.0 |
1.0 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.0 |
0.3 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.4 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.0 |
0.1 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.0 |
5.1 |
GO:0070585 |
protein localization to mitochondrion(GO:0070585) |
| 0.0 |
0.2 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.0 |
0.2 |
GO:0019348 |
polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
| 0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.2 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.0 |
0.1 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.2 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 |
0.1 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.0 |
0.2 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.0 |
0.1 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.0 |
0.2 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.0 |
0.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.1 |
GO:2000484 |
hyaluronan catabolic process(GO:0030214) positive regulation of interleukin-8 secretion(GO:2000484) |
| 0.0 |
0.5 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.0 |
0.1 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.5 |
GO:0051148 |
negative regulation of muscle cell differentiation(GO:0051148) |
| 0.0 |
0.1 |
GO:0033239 |
negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.0 |
0.3 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.0 |
0.1 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.0 |
0.2 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.0 |
0.1 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.0 |
0.2 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 |
0.3 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.0 |
0.2 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.0 |
0.1 |
GO:0036481 |
intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.0 |
1.3 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.0 |
0.5 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 0.0 |
0.3 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 |
0.2 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.0 |
0.1 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.0 |
0.1 |
GO:0016074 |
snoRNA metabolic process(GO:0016074) snoRNA processing(GO:0043144) |
| 0.0 |
0.2 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.0 |
0.1 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 |
0.2 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.0 |
0.2 |
GO:0006734 |
NADH metabolic process(GO:0006734) |
| 0.0 |
0.1 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
0.1 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) |
| 0.0 |
0.1 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.5 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.0 |
0.2 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.0 |
0.2 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.0 |
0.3 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.5 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.0 |
0.4 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.0 |
0.1 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.0 |
0.1 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.0 |
0.2 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.0 |
0.0 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.0 |
0.1 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.0 |
0.1 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.0 |
0.3 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.0 |
0.5 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.0 |
0.2 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.0 |
0.1 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.0 |
0.2 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 |
0.3 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.0 |
0.2 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.0 |
0.0 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.0 |
0.2 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.0 |
0.1 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.0 |
0.4 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.0 |
0.2 |
GO:0042640 |
anagen(GO:0042640) |
| 0.0 |
0.5 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.0 |
0.2 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.0 |
0.3 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
1.3 |
GO:1903322 |
positive regulation of protein modification by small protein conjugation or removal(GO:1903322) |
| 0.0 |
0.2 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
0.3 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.0 |
0.8 |
GO:0060711 |
labyrinthine layer development(GO:0060711) |
| 0.0 |
0.1 |
GO:0051532 |
regulation of NFAT protein import into nucleus(GO:0051532) positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 |
0.4 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.1 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) excitatory synapse assembly(GO:1904861) |
| 0.0 |
0.2 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.0 |
0.8 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.0 |
0.1 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.0 |
0.2 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.0 |
0.2 |
GO:0006098 |
pentose-phosphate shunt(GO:0006098) |
| 0.0 |
0.1 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
0.2 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
0.1 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.0 |
0.6 |
GO:0055013 |
cardiac muscle cell development(GO:0055013) |
| 0.0 |
0.5 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.0 |
0.2 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.0 |
0.1 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.0 |
0.6 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.3 |
GO:0032402 |
melanosome transport(GO:0032402) |
| 0.0 |
0.3 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 |
0.1 |
GO:0071107 |
post-embryonic body morphogenesis(GO:0040032) response to parathyroid hormone(GO:0071107) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.0 |
0.1 |
GO:0042438 |
melanin biosynthetic process(GO:0042438) |
| 0.0 |
0.4 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.0 |
0.2 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.0 |
0.1 |
GO:0009068 |
aspartate family amino acid catabolic process(GO:0009068) |
| 0.0 |
1.4 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.0 |
0.4 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.0 |
0.2 |
GO:0014741 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
| 0.0 |
0.2 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.0 |
0.9 |
GO:0008543 |
fibroblast growth factor receptor signaling pathway(GO:0008543) |
| 0.0 |
0.1 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.0 |
0.2 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.3 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.0 |
0.2 |
GO:0071451 |
cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.0 |
0.1 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.0 |
0.2 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 0.0 |
0.1 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.1 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.0 |
0.4 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.0 |
0.1 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 |
0.1 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.0 |
0.1 |
GO:0009070 |
serine family amino acid biosynthetic process(GO:0009070) |
| 0.0 |
3.5 |
GO:0051260 |
protein homooligomerization(GO:0051260) |
| 0.0 |
0.4 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.0 |
0.3 |
GO:0040018 |
positive regulation of multicellular organism growth(GO:0040018) |
| 0.0 |
0.6 |
GO:0007200 |
phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.0 |
0.3 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.0 |
0.5 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.2 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.0 |
0.3 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.1 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.1 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.3 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.1 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.0 |
0.5 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.7 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 |
0.2 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
0.1 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
0.1 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.0 |
0.0 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.0 |
0.7 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.0 |
0.2 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.0 |
0.3 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.0 |
0.1 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.0 |
0.1 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.0 |
GO:0072683 |
T cell extravasation(GO:0072683) |
| 0.0 |
0.4 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 |
0.0 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.0 |
0.1 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.0 |
0.1 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.0 |
0.5 |
GO:0042542 |
response to hydrogen peroxide(GO:0042542) |
| 0.0 |
0.0 |
GO:0032689 |
negative regulation of interferon-gamma production(GO:0032689) |
| 0.0 |
0.5 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.1 |
GO:0033146 |
regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
| 0.0 |
0.2 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.0 |
0.4 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.0 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.0 |
0.2 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.0 |
0.1 |
GO:0060135 |
maternal process involved in female pregnancy(GO:0060135) |
| 0.0 |
0.0 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) gas homeostasis(GO:0033483) nitric oxide homeostasis(GO:0033484) |
| 0.0 |
0.2 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.0 |
0.2 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.2 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.2 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.0 |
GO:0010814 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.0 |
0.1 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
0.0 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 |
0.1 |
GO:0042026 |
protein refolding(GO:0042026) |
